Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Social Determinants Are Important Barriers to Completion of the Liver Transplant Pathway and Are Associated with Waitlisting and Mortality in Hepatocellular Carcinoma.

Digestive diseases and sciences·2025

Same author

A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction.

Hepatology (Baltimore, Md.)·2025

Same author

Health literacy and cumulative social disadvantage are associated with survival and transplant in patients with hepatocellular carcinoma: a prospective study.

BMJ open gastroenterology·2024

Same author

Weight Loss with an AI-Powered Digital Platform for Lifestyle Intervention.

Obesity surgery·2024

Same author

Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis.

The American journal of gastroenterology·2023

Same author

Quality of epilepsy care in a rural and deprived Scottish population.

Rural and remote health·2023

Search research articles

Related Experiment Video

Updated: May 22, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Cancer prognosis by general practitioners.

Emma Wooff, John Holden

The European Journal of General Practice

|May 18, 2012

Summary

General practitioners (GPs) and hospital doctors show limited accuracy in estimating cancer patient prognoses. Further research is needed to improve these crucial predictions for better patient care.

Area of Science:

Oncology
General Practice
Medical Prognosis

Background:

General practitioners (GPs) frequently encounter patient inquiries regarding cancer prognosis.
A lack of accessible data exists on the accuracy of GP prognostic estimates.

Discussion:

This review identified three studies on GP prognosis estimates in terminal cancer patients.
Findings indicate that GPs accurately estimated prognosis within broad limits for only 25% of patients.
Hospital doctors and nurses demonstrated similar levels of accuracy.

Key Insights:

General practitioners exhibit limited accuracy in predicting cancer patient outcomes.
Prognostic accuracy is comparable across GPs, hospital doctors, and nurses.
There is a significant need for improved methods in cancer prognostication.

Related Experiment Videos

Last Updated: May 22, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Outlook:

Further research in general practice is warranted to enhance prognostic accuracy.
Future studies should focus on developing less complex methodologies.
Improving cancer prognostication can lead to better patient management and care.